title: Effect and mechanism of PAR-2 on the proliferation of esophageal cancer cells.
abstract: Esophageal Cancer (EC) is a common malignant tumor occurred in the digestive tract. In this study, we investigated the mechanism of Protease Activated Receptor 2 (PAR-2) on the proliferation of esophageal cancer cell.
  
  
  
  Transfected esophageal cancer (EC) cell (PAR-2shRNA EC109) was established with low stable PAR-2 expression. EC109 cell was treated with PAR-2 agonist, PAR-2 anti-agonist and MAPK inhibitor respectively; Untreated EC109 cell (blank control) and PAR-2shRNA EC109 cell were used for analysis also. The mRNA expressions of PAR-2, ERK1, Cyclin D1, and c-fos in each group were detected by reverse transcript and polymerase chain reaction. Western blot was used to detect the protein expressions in each group. The cell growth curves were drawn to compare the cell growth.
  
  
  
  Compared with the blank control, the mRNA and protein expressions of PAR-2, Cyclin D1, and c-fos in PAR-2 agonist group increased significantly (p < 0.05), while decreased significantly in PAR-2shRNA EC109 cell and MAPK inhibitor group (p < 0.05). The mRNA expression of ERK1 and protein expression of p-ERK1 increased in PAR-2 agonist group, decreased in PAR-2shRNA EC109 cell and MAPK inhibitor group when compared with blank control (p < 0.05). The growth of cells was upward in PAR-2 agonist group at cell growth phase when compared with blank control, while decreased in PAR-2 shRNA EC109 cell and MAPK inhibitor group with statistical difference (p < 0.05).
  
  
  
  PAR-2 regulate cell proliferation through the MAPK pathway in esophageal carcinoma cell, and Cyclin D1, c-fos are involved in this process.
authors.affiliation: Tianjin Medical University, Tianjin, China. quanjun_deng@126.com.
authors.forename: D
authors.initials: D
authors.lastname: Quanjun
authors.forename: Z
authors.initials: Z
authors.lastname: Qingyu
authors.forename: Z
authors.initials: Z
authors.lastname: Qiliang
authors.forename: X
authors.initials: X
authors.lastname: Liqun
authors.forename: C
authors.initials: C
authors.lastname: Jinmei
authors.forename: L
authors.initials: L
authors.lastname: Ziquan
authors.forename: H
authors.initials: H
authors.lastname: Shike
mesh_terms: D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D019938:Cyclin D1 / Q000378:metabolism; D004938:Esophageal Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D012333:RNA, Messenger; D044464:Receptor, PAR-2 / Q000378:metabolism*
chemical_list: C530104:CCND1 protein, human; D012333:RNA, Messenger; D044464:Receptor, PAR-2; D019938:Cyclin D1